Pharmafile Logo
Pharmafocus logo
Advanced Search
NICE image

NICE starts new wave of quality standards

March 22, 2012
Sales and Marketing Commissioning Board, Future Forum, NHS, NICE

NICE has been given 123 new quality standards to work on, and includes for the first time new standards for …

News
screen_shot_2012-03-22_at_11

Working Life: Mike Crooks, UK general manager, Astellas

March 22, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas Pharma, Mike Crooks, Working Life

 Mike Crooks became general manager of Astellas Pharma in December 2011. He joined Astellas in 2007 as marketing director, becoming …

Feature
GSK image

GSK selects Ulverston for biopharma manufacturing hub

March 22, 2012
Manufacturing and Production, Research and Development, Sales and Marketing Cameron, GSK, Ulverston, manufacturing

GlaxoSmithKline has announced the long-awaited decision on the location of its biopharmaceutical plant in the UK, with Ulverston in Cumbria …

News

NHS faces 10 years of savings, say managers

March 22, 2012
Sales and Marketing NHS, QIPP, Stout, reforms, think tank

The NHS will have to make £40 billion in savings by 2020, meaning budgets will be tighter for longer.  The …

News

Former Roche man Guido Magni joins Versant

March 22, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Versant, appointment, investment firm

Dr Guido Magni is joining US-based firm Versant Ventures as a venture partner to further strengthen the firm’s investment team …

Appointment
Abbott image

Abbott selects ‘AbbVie’ as new name for R&D firm

March 21, 2012
Research and Development, Sales and Marketing Abbott

Abbott has said its new R&D firm will be called AbbVie, and expects to launch the spin-off company at the …

News

Lundbeck appoints new vice president of business development

March 21, 2012
Sales and Marketing

Lundbeck has appointed Jacob Tolstrup as its new vice president with responsibility for the company’s business development. Along with his …

Appointment

Life sciences to benefit from new UK budget plans

March 21, 2012
Sales and Marketing ABPI, BIA, Budget, life sciences, tax

The UK life sciences industry will benefit from a cut in corporation tax and additional funding for academic research. The …

News

British biotech industry gains £200m boost

March 21, 2012
Research and Development, Sales and Marketing GSK, Wellcome Trust, biotech, fund

The Wellcome Trust is to launch a £200 million business that will invest in emerging healthcare and life sciences firms. …

News

Labour defeated in Health Bill debate

March 21, 2012
Sales and Marketing Commons, Lansley, government, health bill

A last ditch effort to stall the passing of the Health Bill was defeated in the Commons last night. The …

News
Eisai logo

Eisai expands UK base

March 21, 2012
Sales and Marketing EMEA, Eisai, Hatfield, expansion

Eisai is expanding its UK headquarters to support the company’s growing European, Middle Eastern and African business. The expansion will …

News
NICE guidance app

NICE launches new guidance app

March 20, 2012
Medical Communications, Sales and Marketing Android, Apple, NICE, app, digital, guidance

NICE has launched a new app that allows mobile access to all of NICE’s recommendations and advice of the past …

News
Merck image

Merck ends development on atrial fibrillation pill

March 20, 2012
Research and Development, Sales and Marketing Cardiome, Merck, atrial fibrillation

Merck will no longer help its partner Cardiome develop an oral formulation of the atrial fibrillation drug vernakalant. The pill …

News

UCB signs £3.6m research deal with Oxford University

March 20, 2012
Research and Development, Sales and Marketing Oxford University, UCB, collaboration, research

UCB Pharma and Oxford University have signed an R&D collaboration agreement covering immunology and neurology. The idea is to pool …

News

NIHR appoints Simon Denegri as national director for public participation and engagement in research

March 20, 2012
Sales and Marketing INVOLVE, NHS, NIHR, Simon Denegri

The National Institute for Health Research (NIHR) has appointed Simon Denegri as its new national director for public participation and …

Appointment
AstraZeneca image

AstraZeneca pulls depression drug, takes $50m hit

March 20, 2012
Research and Development, Sales and Marketing AstraZeneca, R&D, depression, failure, pipeline

AstraZeneca and partner Targacept will not file their depression drug TC-5214 for regulatory review. The decision comes after disappointing Phase …

News

Health Bill clears final Lords hurdle

March 20, 2012
Sales and Marketing Health and Social Care Bill, Lords, NHS, debate, government

The Health and Social Care Bill has passed through the House of Lords, meaning it is on the verge of …

News

EMA completes review of Ben Venue-made drugs

March 19, 2012
Manufacturing and Production Ben Venue, EMA, cancer drugs, production

The European Medicines Agency has recommended that manufacturing of two cancer medicines be transferred from Ben Venue Laboratories plant in …

News

AstraZeneca touting for business at partnering conference

March 19, 2012
Research and Development, Sales and Marketing AstraZeneca, Bio-Europe, R&D, partnering

AstraZeneca is marketing itself as a key partner for drug development deals, ahead of a European partnering conference.  The Bio-Europe …

News

Ranbaxy sets sights on North African pharma market

March 19, 2012
Manufacturing and Production

Indian drugmaker Ranbaxy has opened a new manufacturing facility in Morocco that will help spearhead an expansion of its business …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026